Case Study: Large Pharmaceutical Company Improves Pipeline Decision-Making with Mu Sigma's Market Opportunity Assessment Dashboard

Developed a market opportunity assessment dashboard for a large pharmaceutical company

Large Pharmaceutical Company, a leading global pharma firm, needed a better way to assess the market potential of upcoming oncology molecules amid rising competition, shifting regulations, and a history of trial suspensions and pipeline withdrawals. Mu Sigma helped the customer evaluate whether new drugs were worth pursuing and reduce the risk of late-stage rejections.

Mu Sigma developed a market opportunity assessment dashboard that brought together competitive landscape analysis, competitor profiling, regulatory inputs, price benchmarking, and a weighted product positioning score. The solution improved pipeline decision-making and increased the internal molecule rejection rate from 44% to 62%, helping the company focus on molecules with a higher chance of success and reduce downstream costs.